Karuna Therapeutics surges 47% after Bristol Myers Squibb announces $14 billion deal

1 year ago

Bristol Myers Squibb said it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash. 

More Stories

Donald Trump says Vladimir Putin wants a meeting as soon as possible about the war with Ukraine

7 mins ago

US army says two navy pilots shot down over Red Sea in ‘friendly fire’

8 mins ago

Expelled from Aleppo as children, these fighters returned as its liberators

1 hour ago

Leave a Reply

Your email address will not be published. Required fields are marked *

You may have missed

CHAN Qualifiers: Nigeria’s Super Eagles B hold Ghana’s Black Galaxies

7 mins ago

C-of-O Revocation: Wike targets over N30bn from defaulting Abuja land allottees

7 mins ago

Why our airport is best in West Africa — Ogun Govt

7 mins ago

SO CLOSE! Schindler falls one dart short of a nine-darter!

7 mins ago

Goals galore! Liverpool trump Spurs in NINE-goal bonanza

7 mins ago